Quest Diagnostics Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04B | $2.90B | $2.81B | $2.82B | $2.76B | $2.65B | $2.62B | $2.49B |
| Cost of Revenue | $2.02B | $1.95B | $1.90B | $1.87B | $1.82B | $1.79B | $1.76B | $1.68B |
| Gross Profit | $1.03B | $942.0M | $910.0M | $949.0M | $943.0M | $863.0M | $858.0M | $811.0M |
| Gross Margin | 33.7% | 32.5% | 32.4% | 33.7% | 34.2% | 32.5% | 32.7% | 32.6% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $529.0M | $504.0M | $504.0M | $501.0M | $486.0M | $476.0M | $466.0M | $448.0M |
| Operating Income | $459.0M | $399.0M | $386.0M | $386.0M | $438.0M | $346.0M | $361.0M | $330.0M |
| Operating Margin | 15.1% | 13.8% | 13.8% | 13.7% | 15.9% | 13.0% | 13.8% | 13.3% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $412.0M | $334.0M | $330.0M | $328.0M | $384.0M | $276.0M | $299.0M | $296.0M |
| Income Tax Expense | $88.0M | $74.0M | $81.0M | $77.0M | $97.0M | $59.0M | $68.0M | $65.0M |
| Net Income | $320.0M | $252.0M | $245.0M | $245.0M | $282.0M | $220.0M | $222.0M | $226.0M |
| Net Margin | 10.5% | 8.7% | 8.7% | 8.7% | 10.2% | 8.3% | 8.5% | 9.1% |
| EPS (Basic) | $2.88 | $2.27 | $2.21 | $2.18 | $2.51 | $1.97 | $1.98 | $2.01 |
| EPS (Diluted) | $2.84 | $2.24 | $2.18 | $2.16 | $2.47 | $1.94 | $1.95 | $1.99 |
| Shares Outstanding (Basic) | 111.0M | 110.0M | 111.0M | 112.0M | 112.0M | 111.0M | 111.0M | 112.0M |
| Shares Outstanding (Diluted) | 112.0M | 112.0M | 113.0M | 113.0M | 113.0M | 113.0M | 113.0M | 113.0M |
| Dividends Per Share | $0.86 | $0.86 | $0.80 | $0.80 | $0.80 | $0.80 | $0.75 | $0.75 |